Planet Labs PBC (NYSE:PL) Price Target Raised to $35.00

Planet Labs PBC (NYSE:PL) had its target price boosted by Morgan Stanley from $26.00 to $35.00 in a research report sent to investors on Wednesday,Benzinga reports. The firm currently has an equal weight rating on the stock.

A number of other equities research analysts have also commented on the company. Deutsche Bank Aktiengesellschaft raised their price objective on Planet Labs PBC from $16.00 to $17.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Planet Labs PBC in a research note on Thursday, January 22nd. Zacks Research raised shares of Planet Labs PBC from a “strong sell” rating to a “hold” rating in a research note on Friday, February 13th. Craig Hallum reaffirmed a “buy” rating and issued a $30.00 price target on shares of Planet Labs PBC in a research note on Tuesday, January 13th. Finally, The Goldman Sachs Group reissued a “neutral” rating and set a $16.40 price objective on shares of Planet Labs PBC in a research report on Tuesday, January 20th. Six research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $27.25.

Planet Labs PBC Stock Down 4.5%

NYSE PL opened at $30.93 on Wednesday. Planet Labs PBC has a 12 month low of $2.79 and a 12 month high of $37.05. The company has a market capitalization of $9.70 billion, a P/E ratio of -39.66 and a beta of 1.95. The company’s 50 day simple moving average is $25.76 and its 200 day simple moving average is $18.73. The company has a debt-to-equity ratio of 2.37, a current ratio of 1.65 and a quick ratio of 1.64.

Planet Labs PBC (NYSE:PL) last issued its quarterly earnings results on Thursday, March 19th. The company reported ($0.48) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.43). Planet Labs PBC had a negative return on equity of 69.61% and a negative net margin of 80.22%.The company had revenue of $86.82 million during the quarter, compared to analysts’ expectations of $78.17 million. Planet Labs PBC’s quarterly revenue was up 41.1% on a year-over-year basis. Equities research analysts expect that Planet Labs PBC will post -0.37 earnings per share for the current fiscal year.

Insider Activity

In other Planet Labs PBC news, Director Vijaya Gadde sold 20,000 shares of the stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $26.77, for a total transaction of $535,400.00. Following the transaction, the director owned 250,169 shares in the company, valued at $6,697,024.13. This trade represents a 7.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Kristen Robinson sold 47,835 shares of Planet Labs PBC stock in a transaction that occurred on Wednesday, January 21st. The shares were sold at an average price of $26.96, for a total transaction of $1,289,631.60. Following the completion of the transaction, the director directly owned 222,897 shares in the company, valued at approximately $6,009,303.12. This represents a 17.67% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 218,566 shares of company stock valued at $5,896,276. Insiders own 17.53% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Wellington Shields & Co. LLC grew its position in shares of Planet Labs PBC by 2.8% in the fourth quarter. Wellington Shields & Co. LLC now owns 15,776 shares of the company’s stock valued at $311,000 after purchasing an additional 435 shares during the last quarter. Xponance LLC lifted its position in shares of Planet Labs PBC by 3.1% during the 4th quarter. Xponance LLC now owns 18,656 shares of the company’s stock worth $368,000 after purchasing an additional 555 shares during the last quarter. Wealthfront Advisers LLC lifted its position in shares of Planet Labs PBC by 5.4% during the 4th quarter. Wealthfront Advisers LLC now owns 12,715 shares of the company’s stock worth $251,000 after purchasing an additional 657 shares during the last quarter. Pictet Asset Management Holding SA boosted its stake in Planet Labs PBC by 2.1% during the 4th quarter. Pictet Asset Management Holding SA now owns 33,090 shares of the company’s stock valued at $653,000 after purchasing an additional 690 shares during the period. Finally, Parkside Financial Bank & Trust grew its holdings in Planet Labs PBC by 92.5% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,550 shares of the company’s stock valued at $31,000 after buying an additional 745 shares during the last quarter. Institutional investors and hedge funds own 41.71% of the company’s stock.

Key Planet Labs PBC News

Here are the key news stories impacting Planet Labs PBC this week:

• Positive Sentiment: Planet expanded production capacity in Berlin to serve growing European AI satellite demand — a clear revenue-growth and TAM-expansion signal that investors rewarded with recent price gains. Planet Labs Expands Berlin Production To Serve European AI Satellite Demand
• Positive Sentiment: Analyst upgrades and bullish notes (including a Morgan Stanley call) have lifted sentiment and helped push the stock to new highs; coverage momentum can attract more institutional interest. Morgan Stanley Analyst Says Stock Price Expected to Rise
• Positive Sentiment: Media pieces highlight a very strong 12‑month performance and the company delivering its first full fiscal year of profitability, reinforcing a longer-term growth + earnings narrative. Planet Labs Stock Has Risen 765% in a Year
• Neutral Sentiment: Brokerage consensus sits around “Hold,” suggesting some analysts see upside but others prefer to wait for more proof of sustainable margins and execution. Given Average Recommendation of “Hold” by Brokerages
• Neutral Sentiment: Market commentary highlights the stock’s recent strong performance and notes broader macro headlines driving short-term market volatility — useful context but not company-specific. MarketBeat Week in Review – 03/23 – 03/27
• Negative Sentiment: Planet announced redemption of all outstanding public warrants. That move removes an overhang long term but can trigger near-term selling pressure as warrant holders decide to exercise, sell or accept redemption; it also brings cap‑table and cash/financing implications that investors must parse from the redemption terms. This announcement appears to be the immediate catalyst for the intraday pullback. Planet Labs Announces Redemption of Outstanding Public Warrants Planet Announces Redemption of Public Warrants

About Planet Labs PBC

Planet Labs PBC is a public benefit corporation that operates one of the largest fleets of Earth-imaging satellites, providing high-frequency, high-resolution imagery and data analytics to a broad range of industries. The company’s multi-spectral satellite constellation captures daily snapshots of the planet, enabling clients to monitor changes in agriculture, forestry, urban development, energy infrastructure and environmental conditions. Planet’s imagery platform is designed to support timely decision-making by transforming raw satellite data into actionable insights for business and government users.

Founded in 2010 by former NASA scientists Will Marshall, Robbie Schingler and Chris Boshuizen, Planet Labs grew from a small startup into a key provider in the satellite imaging sector.